<body><script type="text/javascript"> function setAttributeOnload(object, attribute, val) { if(window.addEventListener) { window.addEventListener('load', function(){ object[attribute] = val; }, false); } else { window.attachEvent('onload', function(){ object[attribute] = val; }); } } </script> <div id="navbar-iframe-container"></div> <script type="text/javascript" src="https://apis.google.com/js/platform.js"></script> <script type="text/javascript"> gapi.load("gapi.iframes:gapi.iframes.style.bubble", function() { if (gapi.iframes && gapi.iframes.getContext) { gapi.iframes.getContext().openChild({ url: 'https://www.blogger.com/navbar.g?targetBlogID\x3d33587623\x26blogName\x3dUpdates\x26publishMode\x3dPUBLISH_MODE_BLOGSPOT\x26navbarType\x3dBLUE\x26layoutType\x3dCLASSIC\x26searchRoot\x3dhttps://cohoctonfree.blogspot.com/search\x26blogLocale\x3den_US\x26v\x3d2\x26homepageUrl\x3dhttp://cohoctonfree.blogspot.com/\x26vt\x3d-4325038621838749803', where: document.getElementById("navbar-iframe-container"), id: "navbar-iframe" }); } }); </script>

Updates

 

Abandoned property

The company that was going to rejuvenate the economy of New London, Conn.—the site of the Kelo v. City of New London case, in which the Supreme Court ruled that it was legal for a government to use eminent domain to seize property for private economic development—is pulling out of New London and moving on.

Pfizer, Inc. has merged with Wyeth and just announced that it is moving most of its 1,400 employees to nearby Groton. Opponents of eminent domain are pointing to the move as proof that the development project was ill-conceived from the beginning. Scott Bullock, co-counsel for the case with the Institute for Justice, called Pfizer the "very lynchpin of the project" and said, "All of this really just demonstrates the folly of government abusing eminent domain and granting massive corporate welfare to corporations and to developers." Project supporters argue that the economy is to blame for the development halt.

As reported in "The Buzz" in WORLD Magazine's December 5, 2009 issue.

Labels:

 

for this post

Leave a Reply